What does Dr. S. Vanden Daelen, anesthesie do?

Dr. S. Vanden Daelen, anesthesie is a specialist medical practice in Roeselare. Private Limited, started on 27 May 2020, 1 establishment.

What is the address of Dr. S. Vanden Daelen, anesthesie?

The registered office of Dr. S. Vanden Daelen, anesthesie is located at Stormstraat 24, 8800 Roeselare.

Is Dr. S. Vanden Daelen, anesthesie still active?

Yes. According to the CBE (1 October 2026) Dr. S. Vanden Daelen, anesthesie is active, legal situation “Normale toestand”, started on 27 May 2020.

Is Dr. S. Vanden Daelen, anesthesie registered on Peppol?

Yes, Dr. S. Vanden Daelen, anesthesie is registered on the Peppol network with ID 0208:0747677978.

What is the enterprise number of Dr. S. Vanden Daelen, anesthesie?

The enterprise number of Dr. S. Vanden Daelen, anesthesie is BE0747677978.

When was Dr. S. Vanden Daelen, anesthesie founded?

Dr. S. Vanden Daelen, anesthesie was founded on 27 May 2020.

Who are the directors of Dr. S. Vanden Daelen, anesthesie?

According to the 2025 annual accounts, the directors of Dr. S. Vanden Daelen, anesthesie are: Sophie Vanden Daelen.

Is Dr. S. Vanden Daelen, anesthesie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 May 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. S. Vanden Daelen, anesthesie make in 2025?

Dr. S. Vanden Daelen, anesthesie posted a profit after taxes of € 138,745 in financial year 2025.

What is the revenue of Dr. S. Vanden Daelen, anesthesie?

As a small company, Dr. S. Vanden Daelen, anesthesie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 239,508.

Dr. S. Vanden Daelen, anesthesie (Private Limited)

Dossier Dr. S. Vanden Daelen, anesthesie, printed on 1 October 2026 from databakkes.be/en/0747677978/dr-s-vanden-daelen-anesthesie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. S. Vanden Daelen, anesthesie from Roeselare, company number BE0747677978, closed financial year 2025 with a result of € 138,745 after tax. For that financial year Dr. S. Vanden Daelen, anesthesie recorded a gross margin of € 239,508 and equity of € 543,002. Compared with financial year 2024, the result moved from € 131,202 to € 138,745. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 1, 2026.

What it is worth Healthy

€ 543,002

▼ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 138,745

▲ 6% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 96,252

▲ 72% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 159,050 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 57,285

▼ 24% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 61,382

▼ 36% vs 2024

€ 34,960 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 4,807

▼ 28% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 436

▼ 91% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 239,758 Gross margin 2022: € 239,758 First fiscal year in the series	€ 204,421 Gross margin 2023: € 204,421 ▼ 15% vs 2022 (€ 239,758) Unfavourable step	€ 220,400 Gross margin 2024: € 220,400 ▲ 8% vs 2023 (€ 204,421) Favourable step	€ 239,508 Gross margin 2025: € 239,508 ▲ 9% vs 2024 (€ 220,400) Favourable step	▲ 9%
Profit after taxes	€ 146,525 Profit after taxes 2022: € 146,525 First fiscal year in the series	€ 124,690 Profit after taxes 2023: € 124,690 ▼ 15% vs 2022 (€ 146,525) Unfavourable step	€ 131,202 Profit after taxes 2024: € 131,202 ▲ 5% vs 2023 (€ 124,690) Favourable step	€ 138,745 Profit after taxes 2025: € 138,745 ▲ 6% vs 2024 (€ 131,202) Favourable step	▲ 6%
Equity	€ 309,015 Equity 2022: € 309,015 First fiscal year in the series	€ 432,905 Equity 2023: € 432,905 ▲ 40% vs 2022 (€ 309,015) Favourable step	€ 563,307 Equity 2024: € 563,307 ▲ 30% vs 2023 (€ 432,905) Favourable step	€ 543,002 Equity 2025: € 543,002 ▼ 4% vs 2024 (€ 563,307) Unfavourable step	▼ 4%
Total debts	€ 203,216 Total debts 2022: € 203,216 First fiscal year in the series	€ 146,455 Total debts 2023: € 146,455 ▼ 28% vs 2022 (€ 203,216) Favourable step	€ 107,983 Total debts 2024: € 107,983 ▼ 26% vs 2023 (€ 146,455) Favourable step	€ 67,184 Total debts 2025: € 67,184 ▼ 38% vs 2024 (€ 107,983) Favourable step	▼ 38%
Cash	€ 152,483 Cash 2022: € 152,483 First fiscal year in the series	€ 119,417 Cash 2023: € 119,417 ▼ 22% vs 2022 (€ 152,483) Unfavourable step	€ 55,817 Cash 2024: € 55,817 ▼ 53% vs 2023 (€ 119,417) Unfavourable step	€ 96,252 Cash 2025: € 96,252 ▲ 72% vs 2024 (€ 55,817) Favourable step	▲ 72%
Retained profit	€ 304,015 Retained profit 2022: € 304,015 First fiscal year in the series	€ 427,905 Retained profit 2023: € 427,905 ▲ 41% vs 2022 (€ 304,015) Favourable step	€ 558,307 Retained profit 2024: € 558,307 ▲ 30% vs 2023 (€ 427,905) Favourable step	€ 538,002 Retained profit 2025: € 538,002 ▼ 4% vs 2024 (€ 558,307) Unfavourable step	▼ 4%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 800 Dividend 2023: € 800 Unchanged (€ 800) Unchanged	€ 800 Dividend 2024: € 800 Unchanged (€ 800) Unchanged	€ 159,050 Dividend 2025: € 159,050 ▲ € 158,250 vs 2024 (€ 800) Unchanged	▲ € 158,250
Bank debt	€ 164,450 Bank debt 2022: € 164,450 First fiscal year in the series	€ 130,392 Bank debt 2023: € 130,392 ▼ 21% vs 2022 (€ 164,450) Favourable step	€ 96,039 Bank debt 2024: € 96,039 ▼ 26% vs 2023 (€ 130,392) Favourable step	€ 61,382 Bank debt 2025: € 61,382 ▼ 36% vs 2024 (€ 96,039) Favourable step	▼ 36%
Balance sheet total	€ 512,231 Balance sheet total 2022: € 512,231 First fiscal year in the series	€ 579,360 Balance sheet total 2023: € 579,360 ▲ 13% vs 2022 (€ 512,231) Unchanged	€ 671,290 Balance sheet total 2024: € 671,290 ▲ 16% vs 2023 (€ 579,360) Unchanged	€ 610,187 Balance sheet total 2025: € 610,187 ▼ 9% vs 2024 (€ 671,290) Unchanged	▼ 9%

Key figures of Dr. S. Vanden Daelen, anesthesie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to Dr. S. Vanden Daelen, anesthesie?

What happened at Dr. S. Vanden Daelen, anesthesie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 1, 2026 New annual accounts for financial year 2025: profit of € 138,745 (▲ 6% vs 2024). Source: NBB ↗
May 27, 2020 New establishment in Roeselare. KBO
May 27, 2020 Start of the company according to the CBE. KBO

In short

From € 146,525 profit in 2022 to € 138,745 profit in 2025.

Paid € 231,215 in corporate taxes since 2022.

Best year ever: 2022, with € 146,525 profit.

Paid out € 161,450 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. S. Vanden Daelen, anesthesie? We notify you, reason included.

Follow Dr. S. Vanden Daelen, anesthesie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Sophie Vanden Daelen

Dr. S. Vanden Daelen, anesthesie

Behind Dr. S. Vanden Daelen, anesthesie is Sophie Vanden Daelen.

See the full network in the app

Directors

According to the 2025 annual accounts

Sophie Vanden Daelen

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Stormstraat 24

8800 Roeselare

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0747.677.978
VAT number: BE 0747.677.978
Registered office: Stormstraat 24, 8800 Roeselare
Names & denominations: Dr. S. Vanden Daelen, anesthesie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 27 May 2020
Peppol: Active · Active since 11 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗